FHIR IG Statistics: ValueSet/2.16.840.1.113883.3.464.1003.1150

Resources that use this resource

No resources found

Resources that this resource uses

Narrative

No narrative content found in resource

Source

{
  "resourceType": "ValueSet",
  "id": "2.16.840.1.113883.3.464.1003.1150",
  "meta": {
    "versionId": "12",
    "lastUpdated": "2024-01-24T09:53:01.000-05:00",
    "profile": [
      "http://hl7.org/fhir/StructureDefinition/shareablevalueset",
      "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/computable-valueset-cqfm",
      "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm"
    ]
  },
  "extension": [
    {
      "url": "http://hl7.org/fhir/StructureDefinition/valueset-author",
      "valueContactDetail": {
        "name": "NCQA PHEMUR Author"
      }
    },
    {
      "url": "http://hl7.org/fhir/StructureDefinition/resource-lastReviewDate",
      "valueDate": "2025-03-10"
    },
    {
      "url": "http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate",
      "valueDate": "2024-01-24"
    }
  ],
  "url": "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.1150",
  "identifier": [
    {
      "system": "urn:ietf:rfc:3986",
      "value": "urn:oid:2.16.840.1.113883.3.464.1003.1150"
    }
  ],
  "version": "20240124",
  "name": "SubstanceUseDisorderShortActingMedication",
  "title": "Substance Use Disorder Short Acting Medication",
  "status": "active",
  "date": "2024-01-24T01:11:59-05:00",
  "publisher": "NCQA PHEMUR",
  "jurisdiction": [
    {
      "coding": [
        {
          "system": "urn:iso:std:iso:3166",
          "code": "US"
        }
      ]
    }
  ],
  "purpose": "(Clinical Focus: The purpose of this Grouping value set is to represent concepts for short acting substance use disorder medications.),(Data Element Scope: This value set may use a model element related to Medication.),(Inclusion Criteria: Includes concepts that represent generic, human use and prescribable Acamprosate, Disulfiram, Naltrexone Oral, Buprenorphine Naloxone and Buprenorphine (oral, sublingual) medications.),(Exclusion Criteria: Excludes concepts that represent non-prescribable or branded drugs and excludes concepts that represent components or ingredients. Excludes long acting implant and injection medications.)",
  "compose": {
    "include": [
      {
        "valueSet": [
          "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.1259"
        ]
      }
    ]
  },
  "expansion": {
    "identifier": "urn:uuid:797f7d2c-518b-4ff0-808a-4a629f1a0547",
    "timestamp": "2025-05-23T22:22:43-04:00",
    "total": 21,
    "contains": [
      {
        "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version": "05052025",
        "code": "1010600",
        "display": "buprenorphine 2 MG / naloxone 0.5 MG Sublingual Film"
      },
      {
        "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version": "05052025",
        "code": "1010604",
        "display": "buprenorphine 8 MG / naloxone 2 MG Sublingual Film"
      },
      {
        "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version": "05052025",
        "code": "1307056",
        "display": "buprenorphine 4 MG / naloxone 1 MG Sublingual Film"
      },
      {
        "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version": "05052025",
        "code": "1307061",
        "display": "buprenorphine 12 MG / naloxone 3 MG Sublingual Film"
      },
      {
        "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version": "05052025",
        "code": "1431076",
        "display": "buprenorphine 1.4 MG / naloxone 0.36 MG Sublingual Tablet"
      },
      {
        "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version": "05052025",
        "code": "1431102",
        "display": "buprenorphine 5.7 MG / naloxone 1.4 MG Sublingual Tablet"
      },
      {
        "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version": "05052025",
        "code": "1483744",
        "display": "naltrexone hydrochloride 50 MG Oral Tablet"
      },
      {
        "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version": "05052025",
        "code": "1542390",
        "display": "buprenorphine 2.1 MG / naloxone 0.3 MG Buccal Film"
      },
      {
        "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version": "05052025",
        "code": "1544851",
        "display": "buprenorphine 4.2 MG / naloxone 0.7 MG Buccal Film"
      },
      {
        "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version": "05052025",
        "code": "1544854",
        "display": "buprenorphine 6.3 MG / naloxone 1 MG Buccal Film"
      },
      {
        "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version": "05052025",
        "code": "1597568",
        "display": "buprenorphine 11.4 MG / naloxone 2.9 MG Sublingual Tablet"
      },
      {
        "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version": "05052025",
        "code": "1597573",
        "display": "buprenorphine 8.6 MG / naloxone 2.1 MG Sublingual Tablet"
      },
      {
        "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version": "05052025",
        "code": "1666338",
        "display": "buprenorphine 2.9 MG / naloxone 0.71 MG Sublingual Tablet"
      },
      {
        "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version": "05052025",
        "code": "1864412",
        "display": "buprenorphine 0.7 MG / naloxone 0.18 MG Sublingual Tablet"
      },
      {
        "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version": "05052025",
        "code": "197623",
        "display": "disulfiram 250 MG Oral Tablet"
      },
      {
        "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version": "05052025",
        "code": "197624",
        "display": "disulfiram 500 MG Oral Tablet"
      },
      {
        "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version": "05052025",
        "code": "351264",
        "display": "buprenorphine 2 MG Sublingual Tablet"
      },
      {
        "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version": "05052025",
        "code": "351265",
        "display": "buprenorphine 8 MG Sublingual Tablet"
      },
      {
        "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version": "05052025",
        "code": "351266",
        "display": "buprenorphine 2 MG / naloxone 0.5 MG Sublingual Tablet"
      },
      {
        "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version": "05052025",
        "code": "351267",
        "display": "buprenorphine 8 MG / naloxone 2 MG Sublingual Tablet"
      },
      {
        "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version": "05052025",
        "code": "835726",
        "display": "acamprosate calcium 333 MG Delayed Release Oral Tablet"
      }
    ]
  }
}